Omar Khwaja - 12 Nov 2026 Form 3 Insider Report for WINDWARD BIO GROUP AG (WWB)

SEC form
3
Accepted by SEC
12 Nov 2026, 18:15:14 UTC
Prior SEC filing
25 May 2021
Source filing
View source filing
Filing notes and source

Key filing fact

Omar Khwaja filed Form 3 for WINDWARD BIO GROUP AG (WWB) on 12 Nov 2026.

Key facts

  • This page summarizes Omar Khwaja's Form 3 filing for WINDWARD BIO GROUP AG (WWB).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Nov 2026, 18:15.

Change

  • Previous filing in this sequence was filed on 25 May 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001776393 Primary reporting owner

Khwaja Omar

Relationship
Chief Medical Officer

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WWB holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
642,136
Date
12 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WWB holding Derivative

Employee Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
12 Nov 2026
Ownership
Direct
Underlying class
Common Shares
Underlying amount
318,830
Exercise price
$0.0200
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.

Footnote F2

The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .